封面
市场调查报告书
商品编码
1390621

营运商筛选市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Carrier Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球带因者筛检市场规模达17亿美元。展望未来, IMARC Group预计到2028年市场规模将达到31亿美元,2022-2028年复合年增长率(CAGR)为10.53%。

携带者筛检是一种基因检测技术,用于识别胎儿中可能导致体染色体隐性遗传疾病的异常基因。它是一种预测性和症状前测试解决方案,孕妇和夫妇使用它来分析孩子从父母那里遗传遗传性疾病的风险。它涉及测试唾液、血液或脸颊组织样本,以检测是否存在囊性纤维化、镰状细胞性贫血和泰萨克斯症等疾病的异常基因。这些样本透过基于脱氧核糖核酸 (DNA) 定序、聚合酶炼式反应 (PCR) 和微阵列技术的分子和生化过程进行筛选。它们用于针对各种肺部、血液和神经系统疾病进行扩展、客製化面板、预先设计面板和目标疾病携带者筛检。

营运商筛检市场趋势:

全球胎儿染色体异常和遗传性疾病盛行率的增加是推动市场成长的关键因素之一。此外,大众对早期发现和诊断疾病的好处的认识不断提高,也推动了市场的成长。与此一致的是,分子筛检测试被广泛进行,以识别遗传密码中的DNA突变,并检测可能导致心臟缺陷、白血病前期、听力缺陷和唐氏症的突变。带因者筛检也有助于提供充分的产前和生殖护理,有助于遗传性疾病的适当管理。此外,各种技术进步,例如用于遗传疾病筛检的下一代定序(NGS)技术的开发,也有利于市场成长。其他因素,包括生物技术和生物资讯学领域的广泛研发(R&D)活动,以及医疗基础设施的显着增长,预计将推动市场成长。

本报告回答的关键问题:

  • 迄今为止,全球带因者筛检市场的表现如何?未来几年将如何表现?
  • COVID-19 对全球带因者筛检市场有何影响?
  • 主要区域市场有哪些?
  • 依类型划分市场是怎么样的?
  • 基于医疗状况的市场区隔是什么?
  • 基于技术的市场区隔是什么?
  • 基于最终用户的市场区隔是什么?
  • 产业价值链的各个阶段是什么?
  • 该行业的关键驱动因素和挑战是什么?
  • 全球携带者筛检市场的结构如何?谁是主要参与者?
  • 产业竞争程度如何?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球营运商筛选市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章:按类型分類的市场细分

  • 扩大携带者筛检
    • 市场走向
    • 关键环节
      • 客製化面板测试
      • 预先设计的面板测试
    • 市场预测
  • 针对性疾病带因者筛检
    • 市场走向
    • 市场预测

第 7 章:依医疗状况分類的市场

  • 肺部疾病
    • 市场走向
    • 市场预测
  • 血液学状况
    • 市场走向
    • 市场预测
  • 神经系统疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章:依科技分類的市场

  • DNA定序
    • 市场走向
    • 市场预测
  • 聚合酶炼式反应
    • 市场走向
    • 市场预测
  • 微阵列
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章:最终用户的市场区隔

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 参考实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章:按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章:价值链分析

第 13 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章:价格分析

第15章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Fulgent Genetics
    • Gene By Gene Ltd. (MyDNA)
    • Illumina Inc.
    • Invitae Corporation
    • MedGenome Labs Ltd.
    • Myriad Genetics Inc.
    • Natera Inc.
    • OPKO Health Inc.
    • Quest Diagnostics
    • Sema4
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4417

Abstract

The global carrier screening market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.53% during 2022-2028.

Carrier screening is a genetic testing technique used for the identification abnormal genes in fetuses that can cause autosomal recessive diseases. It is a predictive and pre-symptomatic testing solution used by pregnant individuals and couples to analyze the risks of their child inheriting genetic disorders from the parents. It involves testing a sample of saliva, blood or cheek tissue to detect the presence of an abnormal gene for disorders, such as cystic fibrosis, sickle cell anemia and Tay-Sachs disease. These samples are screened through molecular and biochemical processes based on deoxyribonucleic acid (DNA) sequencing, polymerase chain reaction (PCR) and microarray technologies. They are used for expanded, customized panel, predesigned panel and targeted disease carrier screening for various pulmonary, hematological and neurological disorders.

Carrier Screening Market Trends:

The increasing prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising consciousness among the masses regarding the benefits of early detection and diagnosis of diseases is providing a thrust to the market growth. In line with this, molecular screening tests are widely conducted to identify DNA mutations in the genetic codes and detect the mutations that can cause heart defects, pre-leukemia, hearing defects and down syndrome. Carrier screening also aids in providing adequate prenatal and reproductive care, which facilitates the proper management of heritable diseases. Additionally, various technological advancements, such as the development of next-generation sequencing (NGS) techniques for genetic disease screening, are also favoring the market growth. Other factors, including extensive research and development (R&D) activities in the field of biotechnology and bioinformatics, along with significant growth in the medical infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global carrier screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, medical condition, technology and end user.

Breakup by Type:

Expanded Carrier Screening

Customized Panel Testing

Predesigned Panel Testing

Targeted Disease Carrier Screening

Breakup by Medical Condition:

Pulmonary Conditions

Hematological Conditions

Neurological Conditions

Others

Breakup by Technology:

DNA Sequencing

Polymerase Chain Reaction

Microarrays

Others

Breakup by End User:

Hospitals and Clinics

Reference Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Fulgent Genetics, Gene By Gene Ltd. (MyDNA), Illumina Inc., Invitae Corporation, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Quest Diagnostics, Sema4 and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global carrier screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global carrier screening market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the medical condition?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global carrier screening market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Carrier Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Expanded Carrier Screening
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Customized Panel Testing
      • 6.1.2.2 Predesigned Panel Testing
    • 6.1.3 Market Forecast
  • 6.2 Targeted Disease Carrier Screening
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Medical Condition

  • 7.1 Pulmonary Conditions
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hematological Conditions
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Conditions
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 DNA Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Fulgent Genetics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Gene By Gene Ltd. (MyDNA)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Illumina Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Invitae Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 MedGenome Labs Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Myriad Genetics Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 OPKO Health Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Quest Diagnostics
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sema4
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Carrier Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Carrier Screening Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Carrier Screening Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Carrier Screening Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Carrier Screening Market: Breakup by Medical Condition (in %), 2022
  • Figure 6: Global: Carrier Screening Market: Breakup by Technology (in %), 2022
  • Figure 7: Global: Carrier Screening Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Carrier Screening Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Carrier Screening (Expanded Carrier Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Carrier Screening (Expanded Carrier Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Carrier Screening (Targeted Disease Carrier Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Carrier Screening (Targeted Disease Carrier Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Carrier Screening (Pulmonary Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Carrier Screening (Pulmonary Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Carrier Screening (Hematological Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Carrier Screening (Hematological Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Carrier Screening (Neurological Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Carrier Screening (Neurological Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Carrier Screening (Other Medical Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Carrier Screening (Other Medical Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Carrier Screening (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Carrier Screening (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Carrier Screening (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Carrier Screening (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Carrier Screening (Microarrays) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Carrier Screening (Microarrays) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Carrier Screening (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Carrier Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Carrier Screening (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Carrier Screening (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Carrier Screening (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Carrier Screening (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Carrier Screening (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Carrier Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Carrier Screening Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Carrier Screening Industry: SWOT Analysis
  • Figure 85: Global: Carrier Screening Industry: Value Chain Analysis
  • Figure 86: Global: Carrier Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Carrier Screening Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Carrier Screening Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Carrier Screening Market Forecast: Breakup by Medical Condition (in Million US$), 2023-2028
  • Table 4: Global: Carrier Screening Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Carrier Screening Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Carrier Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Carrier Screening Market: Competitive Structure
  • Table 8: Global: Carrier Screening Market: Key Players